Toniolo Gianluca, Louka Maria, Menounou Georgia, Fantoni Nicolò Zuin, Mitrikas George, Efthimiadou Eleni K, Masi Annalisa, Bortolotti Massimo, Polito Letizia, Bolognesi Andrea, Kellett Andrew, Ferreri Carla, Chatgilialoglu Chryssostomos
ISOF, Consiglio Nazionale delle Ricerche, Via Piero Gobetti 101, 40129 Bologna, Italy.
Institute of Nanoscience and Nanotechnology, N.C.S.R. "Demokritos", 15310 Agia Paraskevi Attikis, Greece.
ACS Omega. 2018 Nov 30;3(11):15952-15965. doi: 10.1021/acsomega.8b02526. Epub 2018 Nov 27.
The use of copper complexes for redox and oxidative-based mechanisms in therapeutic strategies is an important field of multidisciplinary research. Here, a novel Cu(II) complex Cu(TPMA)(Phen) (Cu-TPMA-Phen, where TPMA = tris-(2-pyridylmethyl)amine and Phen = 1,10-phenanthroline) was studied using both the free and encapsulated forms. A hollow pH-sensitive drug-delivery system was synthesized, characterized, and used to encapsulate and release the copper complex, thus allowing for the comparison with the free drug. The human neuroblastoma-derived cell line NB100 was treated with 5 μM Cu-PMA-Phen for 24 h, pointing to the consequences on mono- and polyunsaturated fatty acids (MUFA and PUFA) present in the membrane lipidome, coupled with cell viability and death pathways (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2-tetrazolium viability assay, flow cytometry, microscopy, caspase activation). In parallel, the Cu-TPMA-Phen reactivity with the fatty acid moieties of phospholipids was studied using the liposome model to work in a biomimetic environment. The main results concerned: (i) the membrane lipidome in treated cells, involving remodeling with a specific increase of saturated fatty acids (SFAs) and a decrease of MUFA, but not PUFA; (ii) cytotoxic events and lipidome changes did not occur for the encapsulated Cu-TPMA-Phen, showing the influence of such nanocarriers on drug activity; and (iii) the liposome behavior confirmed that MUFA and PUFA fatty acid moieties in membranes are not affected by oxidative and isomerization reactions, proving the different reactivities of thiyl radicals generated from amphiphilic and hydrophilic thiols and Cu-TPMA-Phen. This study gives preliminary but important elements of copper(II) complex reactivity in cellular and biomimetic models, pointing mainly to the effects on membrane reactivity and remodeling based on the balance between SFA and MUFA in cell membranes that are subjects of strong interest for chemotherapeutic activities as well as connected to nutritional strategies.
在治疗策略中,将铜配合物用于基于氧化还原和氧化作用的机制是多学科研究的一个重要领域。在此,我们对一种新型的铜(II)配合物Cu(TPMA)(Phen)(Cu-TPMA-Phen,其中TPMA = 三(2-吡啶甲基)胺,Phen = 1,10-菲咯啉)的游离形式和包封形式进行了研究。合成并表征了一种中空的pH敏感药物递送系统,用于包封和释放铜配合物,从而能够与游离药物进行比较。用5 μM Cu-PMA-Phen处理人神经母细胞瘤衍生细胞系NB100 24小时,研究其对膜脂质组中存在的单不饱和脂肪酸和多不饱和脂肪酸(MUFA和PUFA)的影响,以及细胞活力和死亡途径(3-(4,5-二甲基噻唑-2-基)-5-(3-羧甲氧基苯基)-2-(4-磺基苯基)-2-四唑盐活力测定、流式细胞术、显微镜检查、半胱天冬酶激活)。同时,利用脂质体模型在仿生环境中研究了Cu-TPMA-Phen与磷脂脂肪酸部分的反应性。主要结果包括:(i)处理后细胞中的膜脂质组,涉及重塑,饱和脂肪酸(SFA)特异性增加,MUFA减少,但PUFA未减少;(ii)包封的Cu-TPMA-Phen未发生细胞毒性事件和脂质组变化,表明此类纳米载体对药物活性的影响;(iii)脂质体行为证实,膜中的MUFA和PUFA脂肪酸部分不受氧化和异构化反应影响,证明了两亲性和亲水性硫醇以及Cu-TPMA-Phen产生的硫自由基的不同反应性。本研究给出了细胞和仿生模型中铜(II)配合物反应性的初步但重要的要素,主要指出了基于细胞膜中SFA和MUFA平衡对膜反应性和重塑的影响,这对于化疗活性以及与营养策略相关的研究具有重要意义。